Product Release vs. Pyrogen Test on each Lot - Medical devices

I

Institute

#1
Hi everybody,
I have some questions about product release (medical devices) concernig pyrogen test. So....After a years of pyrogen testing (rabbit) on each lot we will not be able to do it after the october pass. I search through Iso 13485, MDD and also ISO 10993 series of stand. and tried to find is it obligatory to do pyrogen test on each lot?
I red something about LAL test, do anyone knew how to perform it (pyrogen free water, pyrogen free equipment, laminar flow etc.)?

Thanks for any help!
Tomislav
 
Elsmar Forum Sponsor

Ajit Basrur

Staff member
Admin
#2
Re: Product release vs. pyrogen test

Hi everybody,
I have some questions about product release (medical devices) concernig pyrogen test. So....After a years of pyrogen testing (rabbit) on each lot we will not be able to do it after the october pass. I search through Iso 13485, MDD and also ISO 10993 series of stand. and tried to find is it obligatory to do pyrogen test on each lot?
I red something about LAL test, do anyone knew how to perform it (pyrogen free water, pyrogen free equipment, laminar flow etc.)?

Thanks for any help!
Tomislav
Hi Tomislav,

Welcome to the Cove :bigwave:

The United States Pharmacopeia (USP) has recognized the Limulus Amebocyte Lysate (LAL) method as the official method for carrying out the Bacterial Endotoxins Test. The rabbit pyrogen test may be used only if a product is incompatible with the LAL test.

Limulus amebocyte lysate (LAL) is an aqueous extract of blood cells (amebocytes) from the horseshoe crab, Limulus polyphemus. LAL reacts with bacterial endotoxin or lipopolysaccharide, which is a membrane component of gram negative bacteria. This reaction is the basis of all three LAL test methodologies viz. gel-clot, turbidimetric, and chromogenic.

Gel-clot Method

The gel-clot method is the simplest and most widely used LAL test. The gel-clot test is the compendial method. It is the only endotoxin test fully described in the United States Pharmacopoeia (USP) and many other pharmacopeias. You could use other methods as alternatives also.

Turbidimetric Methods

As the concentration of insoluble coagulin increases during the LAL reaction, the turbidity of the reaction mixture increases. The rate at which turbidity increases is related to the endotoxin concentration in the sample and is the basis of the Turbidimetric methods.

Chromogenic Methods

Chromogenic methods utilize a synthetic substrate which is added to the lysate. When chromogenic LAL reagent reacts with endotoxin, the cascade is initiated and clotting enzyme is activated as in the other methods. The reactions proceed more rapidly at higher endotoxin concentrations.

Refer FDA document - Validation of LAL Test as an end product Endotoxin Test for Human and Animal Parenteral Drugs, Biological Products and Medical Devices .

You could refer to USP General Chapter 85 < Bacterial Endotoxin Test > for more detailed methodology on how to perform this test.
 

yodon

Staff member
Super Moderator
#3
Re: Product release vs. pyrogen test

Ajit,

Great information and a great link provided. I quickly scanned through the document but didn't see the answer to the OP question about performing on every lot. Any thoughts there?
 

Ajit Basrur

Staff member
Admin
#4
Re: Product release vs. pyrogen test

Ajit,

Great information and a great link provided. I quickly scanned through the document but didn't see the answer to the OP question about performing on every lot. Any thoughts there?
I would say that is purely based on the specifications that are defined for the Raw Materials / Finished products.

We had another good discussion thread Endotoxin testing - Raw materials and components of a Class III medical device that can be referred.
 

somashekar

Staff member
Super Moderator
#5
Hi everybody,
I have some questions about product release (medical devices) concernig pyrogen test. So....After a years of pyrogen testing (rabbit) on each lot we will not be able to do it after the october pass. I search through Iso 13485, MDD and also ISO 10993 series of stand. and tried to find is it obligatory to do pyrogen test on each lot?
I red something about LAL test, do anyone knew how to perform it (pyrogen free water, pyrogen free equipment, laminar flow etc.)?

Thanks for any help!
Tomislav
Hii ... Greetings from Somashekar.
I do not know what type of medical device you refer to, however what we do is that we have decided on a lot size and this quantity is always taken up and processed in agreement with the customer. The device concerning us falls under the USP < 20 EU per device catagory. We have a method of assessing the quality of water used in the device processing daily at the beginning of the work by the std LAL gelclot test using the ACC make quick test kit. The process water is certified good when this test passes. Having done this, and progressing further, when the lot quantity is ready for release, the customer picks random samples and the same are identified and sent which are subjected to testing by LAL (Turbidimetric Methods) on the pooled sample, and on the success of this, the customer authorizes the lot release. Its successful and well controlled and this process is established since last 3 years....
Hope this input gives some lead to your question sir.
Regards
Somashekar
 
I

Institute

#6
Hi to all!
Thank you and I apologized for so late answer...I were on vacations.
Still I’am not sure about product release (EU market). We are producing class I sterile and class IIa and if I try to logically think about pyrogen test on nelaton catheter (for example) there are no rational/regulatory explanation why to do test (intended use and some risk assessment are not giving the answer) on each lot. Maybe for administration set (infusion) and transfusion sets are rational to do on each lot regarding to FDA (devices in contact with circulating blood or cerebrospinal fluid) but still I couldn’t find any documents that will mention this.
Ones more I go through MDD, ISO 13485 and GMP (Japan and US) there were no requirements (or I didn’t recognise) for testing pyrogen on each lot.

Tomislav.
 
M

MIREGMGR

#7
For FDA Class II devices the general requirement is that all patient-contact product materials be ISO10993 biocompatible. Non-pyrogenicity is a baseline ISO10993 requirement, so that would apply to all released product. The normal assumption is that materials need be tested only once to qualify them for continued use. This of course assumes that the materials are consistently biocompatible and that the processing does not change their biocompatibility.

If those latter assumptions were not correct, I can understand a self-imposed requirement for batch testing, perhaps incorporated into a 510(k) as a means of finessing what might otherwise be a barrier to FDA approval.

Otherwise, I'm not familiar with a specific FDA requirement for batch pyrogenicity testing of devices for which general materials biocompability has already been established.
 
I

Institute

#8
Thanks Miregmgr!
It is very resonable to do pyrogen test, as you said, only in case if process can influence on biocompatibility issue.

Best regards!
Tomislav
 
D

drewsky1

#9
I found this thread to be very helpful, however it is 2010 and interested if anyone has an update for pyrogen testing on every lot release. We have a devices in contact with circulating blood that we have been pyrogen testing and particle testing respectively on every lot These conditions increase our inspection times from 1 hr to 20 days. In addition, the cost to perform the testing is expensive. Based on the Incoming history that goes back to 1998, we have never had a rejection due to these tests, in other words, the test results have always been accepted. We are considering eliminating this lot testing. Does anyone have any input on recent conventions per FDA, etc on continuous lot testing? It also sounds like from the previous replies that if we did discontinue the pyrogen testing, if anything in the process of the device/component changed, pyrogen testing should be repeated. I appreciate any thoughts on this.
Thanks
Mijenca
 
G

gholland

#10
We do a pyrogen test once per month on each product being produced.

We also push our suppliers to conduct Pyrogen monitoring to reduce the risk of contamination.

We produce Class II devices, mostly bags, tubesets, etc.

I can't think of a reason if your process has been Validated once to produce acceptable product and your parts and process do not change why you would have to do more frequent testing. Our company has been bitten by suppliers that have not controlled their processes in the past therefore we have introduced more stringent requirements.


:2cents:
 
Thread starter Similar threads Forum Replies Date
S Can a Contract Manufacturer "release" product on behalf of client to the market? 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 4
Q Release of the first batch of a cleared product before process validation 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 4
P Records authorizing release of product at Contract Manufacturer ISO 9000, ISO 9001, and ISO 9004 Quality Management Systems Standards 2
G Product Release and Component Classification AS9100, IAQG, NADCAP and Aerospace related Standards and Requirements 1
F What are the requirements for authorized person to release FAA repair shop product AS9100, IAQG, NADCAP and Aerospace related Standards and Requirements 5
T Requirement for a Documented Process for the Review and Release of Product For Sale ISO 13485:2016 - Medical Device Quality Management Systems 6
J Product Release Authorization - Clause 8.2.4 Requirements Nonconformance and Corrective Action 11
Chennaiite Product Release Risk Assessment - Ideas Wanted Design and Development of Products and Processes 2
W Authorizing Product Release while Eliminating In-Process Inspection Records ISO 9000, ISO 9001, and ISO 9004 Quality Management Systems Standards 2
B Records of Customer Order Review and Release of Product ISO 9000, ISO 9001, and ISO 9004 Quality Management Systems Standards 13
M Release of Product without Process Validation ISO 13485:2016 - Medical Device Quality Management Systems 2
D Who should be the person to release product to customer ISO 13485:2016 - Medical Device Quality Management Systems 34
M Product Release - Final acceptance activities and acceptance records ISO 13485:2016 - Medical Device Quality Management Systems 8
C Batch or Lot release in to market - Need product release procedure Document Control Systems, Procedures, Forms and Templates 3
B Release of Nonconforming Product with Concession - 21 CFR 820.90(b)(1) - Class II Nonconformance and Corrective Action 1
K Is more than one Design Control & New Product Release Procedure OK? Design and Development of Products and Processes 3
M Product / Part Release Form examples request Document Control Systems, Procedures, Forms and Templates 1
T Sampling Plan needed for Sampling Product Prior to Release Inspection, Prints (Drawings), Testing, Sampling and Related Topics 3
M 8.2.4 ... person(s) authorizing release of product - Who could this person be? AS9100, IAQG, NADCAP and Aerospace related Standards and Requirements 19
M Lean Manufacturing, SAP and 8.2.4 - No records indicating release of product ISO 9000, ISO 9001, and ISO 9004 Quality Management Systems Standards 1
S Medical Device Product Release Form ISO 13485:2016 - Medical Device Quality Management Systems 5
D Final Release Responsibilities - Separate responsibility for the release of a product ISO 9000, ISO 9001, and ISO 9004 Quality Management Systems Standards 9
Marc Software Releases - When do you release a software product? Software Quality Assurance 2
H Medical device Product Registration Registrars and Notified Bodies 2
A Can a power Supply be an accessory to a medical device, if it is an 'off-the-shelf' product. IEC 60601 - Medical Electrical Equipment Safety Standards Series 3
M Extension to shelf life of new product under MDR EU Medical Device Regulations 1
lanley liao Are there guidelines for application of all API monogrammal product? Oil and Gas Industry Standards and Regulations 2
S ISO 11137- Simulated product vs SIP Other Medical Device Related Standards 2
K "World Class Product" based QM. I need advice. Quality Management System (QMS) Manuals 14
R IATF 16949 Certification for new site with transferred product--what is the impact with CSR and scorecards? IATF 16949 - Automotive Quality Systems Standard 0
William55401 Distributed By Product - Best Practices for Configuration Management and Purchasing Controls ISO 13485:2016 - Medical Device Quality Management Systems 0
R Compatibility studies - combination product CE Marking (Conformité Européene) / CB Scheme 4
R Compatibility studies - Medicinal Product and Medical Device Other ISO and International Standards and European Regulations 0
J Marking "Distributed By" to product with distributors' reference-code EU Medical Device Regulations 3
dinaroxentool Selling a product in Both UK and EU after Brexit UK Medical Device Regulations 8
P EU MDR Translation of Product Name EU Medical Device Regulations 0
N Is this a single integral drug device combination product EU MDR CE Marking (Conformité Européene) / CB Scheme 1
V New Product Model CE Mark Certification under MDR EU Medical Device Regulations 0
Sidney Vianna Informational APQP4Wind - Advanced Product Quality Planning for the Wind Power Supply Chain APQP and PPAP 3
K 510k FDA review, will they accept Biocompatibility result generated using feasibility product lots? 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 8
G Adopting old product - compliance with IEC 62304 IEC 62304 - Medical Device Software Life Cycle Processes 9
S How long does it take to register a product with MHRA? UK Medical Device Regulations 3
D Classification of product for clinical trials EU Medical Device Regulations 14
N Adding unclassified product to the medical device registration US Food and Drug Administration (FDA) 1
B Internal Auditor Competency - Product Auditors Internal Auditing 9
T PFMEA and Control Plans on legacy product FMEA and Control Plans 5
P FDA Approved Product Contact Parts ISO 13485:2016 - Medical Device Quality Management Systems 6
S AS9120B - 8.5.2 Delivering Split Product AS9100, IAQG, NADCAP and Aerospace related Standards and Requirements 6
S Classification of a product according to MDR EU Medical Device Regulations 3
optomist1 Informational Training IMDS - Management of Product Chemical Regulatory Compliance RoHS, REACH, ELV, IMDS and Restricted Substances 2

Similar threads

Top Bottom